Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Francesca M Rossi"'
Autor:
Alberto J. Arribas, Sara Napoli, Luciano Cascione, Giulio Sartori, Laura Barnabei, Eugenio Gaudio, Chiara Tarantelli, Afua Adjeiwaa Mensah, Filippo Spriano, Antonella Zucchetto, Francesca M Rossi, Andrea Rinaldi, Manuel Castro de Moura, Sandra Jovic, Roberta Bordone-Pittau, Alessandra Di Veroli, Anastasios Stathis, Gabriele Cruciani, Georg Stussi, Valter Gattei, Jennifer R. Brown, Manel Esteller, Emanuele Zucca, Davide Rossi, Francesco Bertoni
Publikováno v:
Haematologica, Vol 107, Iss 11 (2022)
PI3Kδ inhibitors are active in patients with lymphoid neoplasms and a first series of them have been approved for the treatment of multiple types of B-cell lymphoid tumors, including marginal zone lymphoma (MZL). The identification of the mechanisms
Externí odkaz:
https://doaj.org/article/1745563a44104ecc87ba453e796f4738
Autor:
Riccardo Bomben, Antonella Zucchetto, Roberta Laureana, Annalisa Chiarenza, Jacopo Olivieri, Erika Tissino, Francesca M. Rossi, Filippo Vit, Tamara Bittolo, Robel Papotti, Federico Pozzo, Annalisa Gaglio, Massimo Degan, Jerry Polesel, Roberto Marasca, Andrea Visentin, Riccardo Moia, Idanna Innocenti, Candida Vitale, Roberta Murru, Marzia Varettoni, Agostino Tafuri, Francesco Zaja, Massimiliano Postorino, Enrica A. Martino, Adalgisa Condoluci, Davide Rossi, Antonio Cuneo, Francesco Di Raimondo, Paolo Sportoletti, Ilaria Del Giudice, Robin Foà, Francesca R. Mauro, Marta Coscia, Luca Laurenti, Gianluca Gaidano, Livio Trentin, Maria I. Del Principe, Massimo Gentile, Valter Gattei
Publikováno v:
HemaSphere, Vol 8, Iss 7, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/667f527bd54b41fab427af43184fb974
Autor:
Alberto J. Arribas, Sara Napoli, Luciano Cascione, Laura Barnabei, Giulio Sartori, Eleonora Cannas, Eugenio Gaudio, Chiara Tarantelli, Afua A. Mensah, Filippo Spriano, Antonella Zucchetto, Francesca M. Rossi, Andrea Rinaldi, Manuel Castro de Moura, Sandra Jovic, Roberta Bordone Pittau, Anastasios Stathis, Georg Stussi, Valter Gattei, Jennifer R. Brown, Manel Esteller, Emanuele Zucca, Davide Rossi, Francesco Bertoni
Publikováno v:
bioRxiv
BTK and PI3K inhibitors are among the drugs approved for the treatment of patients with lymphoid neoplasms. Although active, their ability to lead as single agents to long-lasting complete remission is rather limited especially in the lymphoma settin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::650dbcbfa343bf7d12bdb34071040c0f
https://europepmc.org/articles/PMC9881865/
https://europepmc.org/articles/PMC9881865/
Autor:
Ignacio Sanz, Scott A. Jenks, Matthew C. Woodruff, Cristina Drenkard, Regina Bugrovsky, Francesca M Rossi, S. Sam Lim, Chungwen Wei, Kevin S. Cashman, Laura Aspey, Xiaoqian Wang, Gaobin Bao, Aisha Hill
Publikováno v:
Annals of the Rheumatic Diseases. 80:1190-1200
ObjectiveWhile the contribution of B-cells to SLE is well established, its role in chronic cutaneous lupus erythematosus (CCLE) remains unclear. Here, we compare B-cell and serum auto-antibody profiles between patients with systemic lupus erythematos
Autor:
Alberto J. Arribas, Sara Napoli, Luciano Cascione, Laura Barnabei, Giulio Sartori, Eleonora Cannas, Eugenio Gaudio, Chiara Tarantelli, Afua A. Mensah, Filippo Spriano, Antonella Zucchetto, Francesca M. Rossi, Andrea Rinaldi, Manuel Castro de Moura, Anastasios Stathis, Georg Stussi, Valter Gattei, Jennifer R. Brown, Manel Esteller, Emanuele Zucca, Davide Rossi, Francesco Bertoni
Publikováno v:
Cancer Research. 83:394-394
Background: Marginal zone lymphoma (MZL) is an indolent yet incurable B cell malignancy. Two BTK inhibitors, ibrutinib and zanubrutinib, are FDA approved for relapsed/refractory MZL patients. PI3K inhibitors have also shown clinical activity. The ide
Autor:
Alberto J, Arribas, Sara, Napoli, Luciano, Cascione, Giulio, Sartori, Laura, Barnabei, Eugenio, Gaudio, Chiara, Tarantelli, Afua Adjeiwaa, Mensah, Filippo, Spriano, Antonella, Zucchetto, Francesca M, Rossi, Andrea, Rinaldi, Manuel, Castro de Moura, Sandra, Jovic, Roberta, Bordone-Pittau, Alessandra, Di Veroli, Anastasios, Stathis, Gabriele, Cruciani, Georg, Stussi, Valter, Gattei, Jennifer R, Brown, Manel, Esteller, Emanuele, Zucca, Davide, Rossi, Francesco, Bertoni
PI3Kδ inhibitors are active in patients with lymphoid neoplasms and a first series of them have been approved for the treatment of multiple types of B-cell lymphoid tumors, including marginal zone lymphoma (MZL). The identification of the mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::63925be50b718d05168048be9f603556
https://hdl.handle.net/11391/1543676
https://hdl.handle.net/11391/1543676